M. Sanjurjo-Sáez

发表

Use of the EFQM excellence model to improve hospital pharmacy performance.

C. Rodriguez-Gonzalez, C. Sarobe-González, M. Durán-García, 2020, Research in social & administrative pharmacy : RSAP.

Use of failure mode, effect and criticality analysis to improve safety in the medication administration process.

Ana Herranz-Alonso, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, 2015, Journal of evaluation in clinical practice.

Effectiveness and safety of abatacept in moderate to severe rheumatoid arthritis.

M. Sanjurjo-Sáez, L. Cortejoso-Fernández, M. Romero-Jiménez, 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2018, Journal of evaluation in clinical practice.

Effectiveness of an electronic tool for medication reconciliation in a general surgery department

R. Plá-Mestre, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2015, International Journal of Clinical Pharmacy.

Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2019, Applied Clinical Informatics.

Individualized therapy in patients with Fabry disease: is it a feasible strategy for rare diseases?

M. Sanjurjo-Sáez, M. Pernía-López, S. Manrique-Rodríguez, 2016 .

Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Expert opinion on drug safety.

New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

M. Sanjurjo-Sáez, L. López-Fernández, F. Thomas, 2020, Cancer Chemotherapy and Pharmacology.

Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis

M. Sanjurjo-Sáez, J. López-Gómez, V. Escudero-Vilaplana, 2013, International Journal of Clinical Pharmacy.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, JMIR mHealth and uHealth.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis (Preprint)

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2019 .

Validation of a method for recording pharmaceutical interventions

M. Durán-García, M. Sanjurjo-Sáez, C. Fernández-Llamazares, 2012, Journal of clinical pharmacy and therapeutics.

Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome

M. Sanjurjo-Sáez, V. Escudero-Vilaplana, R. Romero-Jimenez, 2016, Journal of clinical pharmacy and therapeutics.

Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. Herrera-Gutiérrez, 2020, Drugs in R&D.

Pharmaceutical care in paediatric intensive care unit: activities and interdisciplinary learning in a Spanish hospital

M. Sanjurjo-Sáez, J. López‐Herce, I. García-López, 2012 .

The use of autologous serum eye drops for the treatment of ocular surface disorders

M. Sanjurjo-Sáez, E. Garcia-Martin, Sagrario Pernía-López, 2018, European journal of hospital pharmacy : science and practice.

Prevention and treatment of intraluminal catheter thrombosis in children hospitalised in a paediatric intensive care unit

M. Sanjurjo-Sáez, C. Fernández-Llamazares, S. Manrique-Rodríguez, 2014, Journal of paediatrics and child health.

Treatment and prophylaxis of catheter-related thromboembolic events in children.

M. Sanjurjo-Sáez, C. Fernández-Llamazares, S. Manrique-Rodríguez, 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Pharmacotherapeutic review and update of idiopathic nephrotic syndrome in children

M. Sanjurjo-Sáez, C. Fernández-Llamazares, S. Manrique-Rodríguez, 2010, Pharmacy World & Science.

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Journal of clinical pharmacy and therapeutics.

Safe intravenous administration in pediatrics: A 5-year Pediatric Intensive Care Unit experience with smart pumps.

M. Sanjurjo-Sáez, C. Fernández-Llamazares, S. Manrique-Rodríguez, 2016, Medicina intensiva.

Safe intravenous administration in pediatrics: A 5-year Pediatric Intensive Care Unit experience with smart pumps

M. Sanjurjo-Sáez, S. Manrique-Rodríguez, Á. Carrillo-Álvarez, 2016 .

Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

F. Fernández‐Avilés, H. Bueno, A. Herranz-Alonso, 2014, International Journal of Clinical Pharmacy.

Mobile Health Apps Related to Emergency Drugs: Systematic Search on App Stores and Content Analysis (Preprint)

A. Herranz-Alonso, M. Sanjurjo-Sáez, Beatriz Somoza-Fernández, 2021 .

Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

F. Fernández‐Avilés, H. Bueno, C. Rodriguez-Gonzalez, 2016, International journal of clinical practice.

Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission

A. Herranz-Alonso, M. Sanjurjo-Sáez, E. Duran-Garcia, 2015, European journal of hospital pharmacy. Science and practice.

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2013, Clinical and experimental rheumatology.

Pharmacogenetics of trough serum anti‐TNF levels in paediatric inflammatory bowel disease

M. Sanjurjo-Sáez, L. López-Fernández, E. Martínez-Ojinaga, 2020, British journal of clinical pharmacology.

Impact of the endorse study results on thromboprophylaxis prescribing patterns in medical patients attending the Emergency Department

M. Durán-García, M. Sanjurjo-Sáez, C. Pascual Izquierdo, 2015, International journal of clinical practice.

Antiangiogenic Drugs and Cardiogenic Shock: A Case Report

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, L. Cortejoso, 2014, American journal of therapeutics.

Adequacy of Thromboembolic Prophylaxis Prescribed in an Emergency Department

A. Herranz-Alonso, M. Sanjurjo-Sáez, E. Duran-Garcia, 2013 .

Pazopanib-Associated Transient Ischemic Attack.

M. Sanjurjo-Sáez, V. Escudero-Vilaplana, J. L. Revuelta-Herrero, 2018, American journal of therapeutics.

The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital

M. Sanjurjo-Sáez, C. Fernández-Llamazares, V. Escudero-Vilaplana, 2014, Journal of clinical pharmacy and therapeutics.

Developing a drug library for smart pumps in a pediatric intensive care unit

María Sanjurjo-Sáez, Silvia Manrique-Rodríguez, Amelia Sánchez-Galindo, 2012, Artif. Intell. Medicine.

Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results.

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2022, Injury.

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain

M. Sanjurjo-Sáez, L. López-Fernández, Sara Salvador-Martín, 2022, Pharmaceutics.

Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

M. Sanjurjo-Sáez, L. López-Fernández, E. Martínez-Ojinaga, 2020, Journal of pediatric gastroenterology and nutrition.

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co‐administration

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2016, Journal of clinical pharmacy and therapeutics.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022, Frontiers in Public Health.

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein.

A. Herranz-Alonso, M. Sanjurjo-Sáez, I. Iglesias-Peinado, 2018, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Revista brasileira de anestesiologia.

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

A. Dopazo, M. Sanjurjo-Sáez, L. López-Fernández, 2021, Pharmaceutics.

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease

M. Sanjurjo-Sáez, L. López-Fernández, E. Martínez-Ojinaga, 2020, International journal of molecular sciences.

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

M. Sanjurjo-Sáez, L. López-Fernández, C. Grávalos, 2018, Pharmacological research.

Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2018, The Annals of pharmacotherapy.

Switching to a rilpivirine/emtricitabine/tenofovir single‐tablet regimen in RNA‐suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2017, International journal of clinical practice.

Smartphone applications for cancer patients; what we know about them?

Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Sáez, 2016, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, International Journal of Clinical Pharmacy.

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort.

C. Rodriguez-Gonzalez, M. Durán-García, A. Herranz-Alonso, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Journal of Cancer Research and Clinical Oncology.

Thalidomide as treatment of refractory thoracic Rosai‐Dorfman disease

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Journal of clinical pharmacy and therapeutics.

Acyclovir and Hyponatremia: A Case Report

M. Durán-García, M. Sanjurjo-Sáez, M. Gómez-Antúnez, 2014, American journal of therapeutics.

Information leaflets for patients with hepatitis C receiving treatment with triple therapy

C. Rodriguez-Gonzalez, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2012 .

Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2020, The Annals of pharmacotherapy.

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

M. Sanjurjo-Sáez, E. Laserna-Mendieta, A. Lucendo, 2023, International journal of molecular sciences.

Differential Expression of SMAD Genes and S1PR1 on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn’s Disease

M. Sanjurjo-Sáez, M. L. Martin-Barbero, M. Martínez-Ginés, 2020, International journal of molecular sciences.

Genetic predictors of long-term response and trough levels of infliximab in Crohn's disease.

M. Sanjurjo-Sáez, E. Laserna-Mendieta, A. Lucendo, 2019, Pharmacological research.

Appropriateness of Empirical Antibiotic Therapy for Cervicitis and Urethritis Prescribed in the Emergency Department

M. Sanjurjo-Sáez, C. Fernández-Llamazares, A. Castuera-Gil, 2022, Hospital pharmacy.

Pharmacotherapy follow‐up of key points in the safety of oral antineoplastic agents

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2017, European journal of cancer care.

Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report

M. Sanjurjo-Sáez, E. Garcia-Martin, Sagrario Pernía-López, 2017, European journal of hospital pharmacy. Science and practice.

Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study

A. Herranz-Alonso, M. Sanjurjo-Sáez, T. Mombiela, 2021, BMC Pulmonary Medicine.

Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain

M. Sanjurjo-Sáez, C. Fernández-Llamazares, E. Duran-Garcia, 2012, European Journal of Clinical Pharmacology.

Impact of clinical pharmacist interventions in reducing paediatric prescribing errors

M. Sanjurjo-Sáez, C. Fernández-Llamazares, E. Duran-Garcia, 2012, Archives of Disease in Childhood.

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Frontiers in Oncology.

Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: a bundle of interventions including health information technologies.

C. Rodriguez-Gonzalez, M. Sanjurjo-Sáez, M. Sánchez-Somolinos, 2018, European journal of hospital pharmacy : science and practice.

Cancellations of elective surgical procedures due to inadequate management of chronic medications

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, S. Ibáñez-García, 2019, Journal of clinical pharmacy and therapeutics.

Prevalence of medication administration errors in two medical units with automated prescription and dispensing

Ana Herranz-Alonso, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, 2012, J. Am. Medical Informatics Assoc..

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2018, Journal of medical Internet research.

DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach

M. Sanjurjo-Sáez, L. López-Fernández, F. Thomas, 2021, Journal of personalized medicine.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Expert opinion on drug safety.

Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis

Ana Herranz-Alonso, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, 2020, Journal of medical Internet research.

Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice

M. Sanjurjo-Sáez, R. García-Vicuña, V. Escudero-Vilaplana, 2015, International Journal of Clinical Pharmacy.

Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Patient-reported outcomes and mobile applications . A review of their impact on patients ’ health outcomes Patient-reported outcomes

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022 .

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, JMIR mHealth and uHealth.

Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

M. Sanjurjo-Sáez, J. L. Revuelta-Herrero, A. de Lorenzo-Pinto, 2019, International Journal of Clinical Pharmacy.

Impact of fampridine on quality of life: clinical benefit in real-world practice

M. Sanjurjo-Sáez, A. Herranz, J. G. García Domínguez, 2017, European journal of hospital pharmacy. Science and practice.

Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2023, European journal of hospital pharmacy : science and practice.

Adding value through pharmacy validation: a safety and cost perspective.

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2016, Journal of evaluation in clinical practice.

Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain

M. Sanjurjo-Sáez, C. Fernández-Llamazares, E. Duran-Garcia, 2012, European Journal of Clinical Pharmacology.

Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure.

M. Durán-García, M. Sanjurjo-Sáez, P. Arrabal-Durán, 2014, Nefrología.

Promoting clinical pharmacy services through advanced medication review in the emergency department

M. Sanjurjo-Sáez, A. Herranz, A. de Lorenzo-Pinto, 2018, European journal of hospital pharmacy : science and practice.

Variability in management and outcomes of therapy with eculizumab in atypical hemolytic uremic syndrome

M. Sanjurjo-Sáez, S. Manrique-Rodríguez, C. Martínez Fernández-Llamazares, 2019 .

Implementing smart pump technology in a pediatric intensive care unit: A cost-effective approach

María Sanjurjo-Sáez, Silvia Manrique-Rodríguez, Amelia Sánchez-Galindo, 2014, Int. J. Medical Informatics.

Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.

M. Sanjurjo-Sáez, L. López-Fernández, V. Navas-López, 2023, Pharmacological research.

Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Implementation of smart pump technology in a paediatric intensive care unit

María Sanjurjo-Sáez, Silvia Manrique-Rodríguez, Amelia Sánchez-Galindo, 2015, Health Informatics J..

Eosinophilia secondary to lenalidomide therapy

M. Sanjurjo-Sáez, V. Escudero-Vilaplana, R. Collado-Borrell, 2018, Journal of clinical pharmacy and therapeutics.

Clinical and Economic Impact of a Multisciplinary Intervention to Reduce Bleeding Risk in Patients With Acute Coronary Syndrome.

H. Bueno, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2017, Revista espanola de cardiologia.

Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury.

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2020, American journal of therapeutics.

Preparation of Intravenous Drug Administration Guidelines for a Pediatric Intensive Care Unit

M. Sanjurjo-Sáez, C. Fernández-Llamazares, J. López‐Herce, 2014, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

DD-014 Staff satisfaction after the implementation of a robotic dispensing system in an outpatient pharmacy

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016 .

Thromboprophylaxis Management in Surgical Patients: The Efficacy of a Protocol in the Electronic Prescription Program

M. Sanjurjo-Sáez, A. Ribed, F. Chana-Rodríguez, 2019, Quality management in health care.

Cardiovascular Toxicity and Sorafenib: A Case Report

M. Sanjurjo-Sáez, A. Gimenez-Manzorro, L. Cortejoso, 2014, American journal of therapeutics.

Smart pump alerts: All that glitters is not gold

María Sanjurjo-Sáez, Silvia Manrique-Rodríguez, Amelia Sánchez-Galindo, 2012, Int. J. Medical Informatics.

[TRANSLATED ARTICLE] Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.

Perceval Vellosillo, M. Sanjurjo-Sáez, L. López-Fernández, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, JMIR mHealth and uHealth.

Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario

M. Sanjurjo-Sáez, I. Sousa-Casasnovas, X. García-González, 2024, International journal of molecular sciences.

Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports

M. Sanjurjo-Sáez, C. Fernández-Llamazares, S. Manrique-Rodríguez, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

M. Sanjurjo-Sáez, A. de Lorenzo-Pinto, C. Ortega-Navarro, 2019, International Journal of Clinical Pharmacy.

Smartphone applications for cancer patients; what we know about them?

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.